Home
David D. Chang, President and CEO: Allogene Therapeutics ALLO Sell · Filed 03/18
Trade details
- Type
- Insider sale
- Amount
- $117,974.61
- Shares · price
- 47,763 sh · $2.47 a share
- Held after
- 5,150,599 sh
- Trade date
- 26/03/16
- Filed
- 26/03/18
- Days to filing
- 2 days
Sold 0.9% of holdings
- Share of holding sold
- 0.9%
Allogene Therapeutics trades, last 26 weeks
What else happened in Allogene Therapeutics around then
Filed or reported within 30 days of the trade day · 02/14~04/15David D. Chang's recent trades
- David D. Chang
Planned saleAllogene Therapeutics
Planned saleAllogene Therapeutics
ALLO
$117.8K
47,763 sh
$117.8K
Filed 03/16
Traded 03/16
- David D. Chang
SellAllogene Therapeutics
SellAllogene Therapeutics
ALLO
$171.5K
95,269 sh
$171.5K
Filed 02/04
Traded 02/02
- David D. Chang
Planned saleAllogene Therapeutics
Planned saleAllogene Therapeutics
ALLO
$438.5K
243,976 sh
$438.5K
Filed 02/02
Traded 02/02
- David D. Chang
SellAllogene Therapeutics
SellAllogene Therapeutics
ALLO
$91.5K
46,668 sh
$91.5K
Filed 25/03/18
Traded 25/03/14
- David D. Chang
Planned saleAllogene Therapeutics
Planned saleAllogene Therapeutics
ALLO
$91.5K
46,668 sh
$91.5K
Filed 25/03/14
Traded 25/03/14